SCHEMBL21020006

SCHEMBL21020006

Cc1ccccc1N(C)c1cccc2c1sc1c(C(C)C)cccc12

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 1/20 0.35
LMNA P02545 2/20 0.33
MEN1 O00255 1/20 0.31
KMT2A Q03164 1/20 0.31
HSD17B1 P14061 1/20 0.31
HSD17B2 P37059 1/20 0.31
FAAH O00519 1/20 0.30
CA1 P00915 1/20 0.30
CA2 P00918 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
GABRA1 P14867 1/20 0.30
HPGD P15428 1/20 0.30
TSHR P16473 1/20 0.30
GABRB1 P18505 1/20 0.30
GABRG2 P18507 1/20 0.30
PTGS1 P23219 1/20 0.30
SLC6A2 P23975 1/20 0.30
HTR2C P28335 1/20 0.30
GABRB3 P28472 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20172876 0.89 SIGMAR1 (0.35) SIGMAR1LMNAMEN1KMT2AFAAH
SCHEMBL21020588 0.87 LMNA (0.33) SIGMAR1LMNAMEN1KMT2ACYP1A2
SCHEMBL20172875 0.85 CYP1A2 (0.35) SIGMAR1HSD17B1HSD17B2CYP1A2ALDH1A1
SCHEMBL21020009 0.82 NPC1 (0.34) SIGMAR1MEN1KMT2ACYP1A2
SCHEMBL21021038 0.82 SIGMAR1 (0.33) SIGMAR1
SCHEMBL21020455 0.82 SIGMAR1 (0.32) SIGMAR1TSHRALDH1A1
SCHEMBL21021048 0.81 P2RX7 (0.35) SIGMAR1
SCHEMBL21020432 0.80 LMNA (0.40) LMNAFAAHCA1CA2CYP1A2
SCHEMBL20172885 0.79 ACHE (0.37) LMNAHSD17B1HSD17B2CYP1A2TSHR
SCHEMBL20172866 0.79 GPR3 (0.41) LMNAMEN1KMT2AHSD17B1HSD17B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190152919-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2019-05-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190152919-A1 COMPOUND AND ORGANIC ELECTRONIC ELEMENT COMPRISING SAME OR10J3, ETV6, ESR1 SIGMAR1 2480/4885LMNA 3923/4885MEN1 565/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.